| Individuals known to have had an anaphylactic or severe systemic reaction to human globulin should not recieve hepatitis B immune globulin. Individuals deficient in IgA may have potential to develop IgA antibodies and have an anaphylactoid reaction. Physician to weigh potential benefit of treatment against hypersensitivity reaction. |